Sideroblastic anaemia associated with lincomycin therapy.
Sideroblastic anaemia developed after lincomycin therapy in a 58-year-old woman. The anaemia proved completely reversible after termination of lincomycin therapy and the introduction of pyridoxine. The patient also had pseudomembranous enterocolitis, a well-known side effect of lincomycin.
D000756:Anemia, Sideroblastic / Q000139:chemically induced*; D004761:Enterocolitis, Pseudomembranous / Q000139:chemically induced; D005260:Female; D006801:Humans; D008034:Lincomycin / Q000009:adverse effects*; D008875:Middle Aged
D008034:Lincomycin